Protagonist Therapeutics Inc (PTGX)
Operating profit margin
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 148,678 | -93,652 | -153,217 | -147,194 | -146,283 | -131,373 | -131,873 | -133,496 | -122,935 | -125,845 | -107,659 | -81,505 | -68,840 | -64,516 | -62,985 | -72,380 | -85,570 | -80,521 | -78,634 | -70,856 |
| Revenue (ttm) | US$ in thousands | 315,090 | 60,137 | 123 | 123 | 982 | 26,704 | 35,221 | 45,507 | 46,913 | 27,380 | 24,330 | 27,139 | 31,091 | 28,549 | 25,678 | 12,604 | 6,408 | 4,321 | 3,955 | 10,051 |
| Operating profit margin | 47.19% | -155.73% | -124,566.67% | -119,669.92% | -14,896.44% | -491.96% | -374.42% | -293.35% | -262.05% | -459.62% | -442.49% | -300.32% | -221.41% | -225.98% | -245.29% | -574.26% | -1,335.36% | -1,863.48% | -1,988.22% | -704.96% |
March 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $148,678K ÷ $315,090K
= 47.19%
Protagonist Therapeutics Inc's operating profit margin has shown significant fluctuations over the quarters, ranging from negative percentages to extremely high positive percentages. The operating profit margin was very low or negative in most periods, indicating that the company's operating expenses were high relative to its revenue.
The operating profit margin was particularly unfavorable in the most recent quarter, ending March 31, 2024, where it stood at 47.19%. This indicates that the company was able to generate a profit from its core operations during this period.
However, in previous quarters, the operating profit margins were extremely negative, suggesting that the company may have been facing challenges in controlling costs and improving operational efficiency. The negative operating profit margins, especially in the range of thousands of percentage points, are highly concerning and may indicate severe financial distress for the company.
Overall, Protagonist Therapeutics Inc's operating profit margin analysis highlights the need for the company to focus on streamlining operational costs and improving operational performance to enhance profitability and sustainability in the long term.
Peer comparison
Mar 31, 2024